Please select the option that best describes you:
How do you approach CLL in a patient not currently on treatment who has a solid tumor that requires treatment?
Do you worry about their marrow reserve and response to neulasta in terms of lymphocytosis and decreased ANC response?
Answer from: Medical Oncologist at Academic Institution
This is a very pertinent question for all of us who treat patients with CLL.
Patients with CLL mostly are elderly in age.
Second cancer occurs more often in one with CLL than in the population without CLL. These second cancers can be in any organ, but the frequent sites are skin, GI tract, and l...
Sign in or Register to read more
Answer from: Medical Oncologist at Academic Institution
Use of G-CSF is not an issue for patients with CLL and they tend to respond well to G-CSF.